Developer docs
API playgroundTry for free, no card

Search company profiles

Taconic Biosciences

Full company profile

uuid0005ycn

Namestring
Taconic Biosciences
Legal namestring
Taconic Biosciences, Inc.
Websiteurl
taconic.com
Company typeenum
Private
Founded yearint
1952
Descriptiontext

Taconic Biosciences is a US-headquartered, privately held supplier of genetically engineered rodent models and preclinical research services, founded in 1949 and operating facilities in Germantown and Hudson, New York, with additional offices in Copenhagen, Denmark, and a France-based subsidiary (TransCure bioServices) acquired in January 2026. The company's portfolio centers on proprietary mouse and rat models — including the CIEA NOG immunodeficient platform, humanized immune system (HIS) variants such as NOG-EXL, NOG-hIL-2/6/15, FcResolv, and the NeoThy engraftment platform — as well as standard strains, diet-induced disease models (DIO B6, MASH B6), and germ-free mice. Custom model generation is delivered through the ExpressMODEL platform using CRISPR/Cas9, ES cell targeting, and random insertion transgenesis, supported by the eTACONIC project management portal.

Taconic generates revenue through per-unit model sales (e.g., $17 for Swiss Webster, $36 for Sprague Dawley, $105 for DIO B6), project-based custom model development, and recurring colony management, breeding, and cryopreservation services. Additional service revenue comes from flow cytometry, genotyping, microbiome, biospecimen collection, and — following the TransCure acquisition — translational pharmacology and preclinical imaging. The go-to-market is direct enterprise sales via scientific account representatives serving three primary segments: pharmaceutical and biopharma companies, academic and university research institutions, and biotech companies. Taconic is recognized as one of three major global preclinical rodent model suppliers alongside Charles River and Jackson Laboratory, and it maintains multi-channel marketing through scientific conferences, the eTACONIC platform, and an academic grant program that includes the Smart Select free-trial offering.

Short descriptiontext

Taconic Biosciences is a privately held US-based supplier of genetically engineered rodent models and humanized mouse platforms for pharmaceutical, biotech, and academic preclinical research, offering custom model generation, colony management, and translational research services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersAlbany, United States
HQ citystring
Albany
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
preclinical rodent models, humanized mouse models, genetically engineered mice, colony management services, custom model generation
Industry1 code
PRIMARYHLAAAIAC
Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Preclinical Research Models
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Research Model Sales
TypeOne Time License
Description

Sale of standardized and specialty mouse and rat models including immunodeficient, humanized, and genetically engineered strains. Revenue generated through per-unit pricing of individual animals with varying prices based on strain, age, and genetic background.

taconic.com
2Custom Model Development Services
TypeOne Time License
Description

ExpressMODEL® program providing custom genetically engineered rodent model generation for researchers requiring specific genetic modifications. Projects scoped and priced based on model complexity and development timeline requirements.

taconic.com
3Colony Management and Breeding Services
TypeSubscription Recurring
Description

Ongoing colony management, breeding, and production services for researchers requiring continuous supply of specific model strains. Services include colony expansion, cryopreservation, and rederivation.

taconic.com
4Scientific Consultation Services
TypeProfessional Services
Description

Technical and scientific consultation on model selection, experimental design, and study implementation for preclinical research programs. Often bundled with product sales for enterprise customers.

taconic.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details3 tiers
1Swiss Webster Mouse - Standard pricing for outbred research mice
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$17.00 per female mouse (3-4 weeks of age). Outbred strain commonly used for general research, toxicology, and efficacy studies.

taconic.com
2DIO B6 Mice - Diet-induced obesity model on C57BL/6 background
ModelUnit PricingBilling cadencePay-as-you-go
Notes

DIO B6 Males (7-9 weeks): $105.00 per mouse. Control B6 Males (7-9 weeks): $39.00 per mouse. High-fat diet induced obesity model for metabolic and obesity research.

taconic.com
3Sprague Dawley Rat - Standard outbred rat model
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$36.25 per female rat (3-4 weeks of age). Widely used outbred rat strain for toxicology, pharmacology, and metabolic research studies.

taconic.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1eTACONIC® Platform
Description

Customer portal for custom breeding services providing real-time access to colony inventory.

taconic.com
+1 more record
Core offering1 text field

Taconic Biosciences develops, breeds, and sells genetically engineered mouse and rat models along with supporting laboratory and colony management services for biomedical and preclinical drug discovery research. The portfolio includes immunodeficient and humanized mouse models (notably the NOG family), standard inbred and outbred strains, diet-induced disease models, and custom-generated models via the ExpressMODEL® platform, sold primarily to pharmaceutical companies, biotechnology firms, and academic research institutions.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Taconic Biosciences is a global leader in genetically engineered rodent models and preclinical research services. The company's portfolio centers on mouse and rat models including genetically engineered models (knockout, knock-in, transgenic), immunodeficient models (NOG mice, humanized immune system mice), standard strains, and diet-induced disease models. Key product lines include the NOG mouse portfolio for immuno-oncology research, humanized mouse platforms (NeoThy, Humanized Liver), and metabolic disease models (DIO B6, Diet Induced MASH). Services encompass custom model generation (via ExpressMODEL CRISPR platform), colony management, flow cytometry, cryopreservation, microbiome solutions, and biospecimen collection. The company operates the eTACONIC customer portal for project tracking. Following the January 2026 acquisition of TransCure bioServices, the portfolio expanded to include translational pharmacology and preclinical imaging services.

Product and service30 records
1Genetically Engineered Models (GEMs)
CategoryGenetically Engineered Rodent Models
Description

Genetically engineered mouse and rat models including knockout, knock-in, transgenic, knockdown, and cryopreserved variants for preclinical research and drug discovery. Targeted at pharmaceutical, biotechnology, and academic research customers.

2CIEA NOG Mouse
CategoryImmunodeficient Mouse Models
Description

Super immunodeficient NOG mouse model for oncology and immuno-oncology research, enabling human tissue engraftment for translational studies. Targeted at preclinical researchers studying human cancer and immune system function.

3Humanized Immune System (HIS) Mice
CategoryHumanized Mouse Models
Description

Human immune system engrafted mouse models enabling predictive evaluation of immunotherapies and immune-mediated responses. Targeted at immuno-oncology and immunology researchers in pharma and academia.

4NeoThy Human Immune Engraftment Platform
CategoryHumanized Mouse Models
Description

Human immune engraftment platform enabling physiologic human immune function in mice through thymic tissue and HSC engraftment, supporting HLA-restricted T cell development for immunology and immuno-oncology research.

5Humanized Liver Mouse Platform
CategoryHumanized Mouse Models
Description

Human hepatocyte-engrafted TK-NOG mice platform for liver-focused drug development and in vivo pharmacology services. Targeted at hepatology, infectious disease, and drug metabolism researchers.

6FcResolv NOG Models
CategoryHumanized Mouse Models
Description

Fc-engineered NOG mouse models designed for oncology research evaluating Fc-mediated antibody effector functions. Targeted at antibody therapeutic developers.

7huNOG-EXL Model Portfolio
CategoryHumanized Mouse Models
Description

Next-generation humanized NOG-EXL mouse models expressing human cytokines (hGM-CSF/hIL-3) for enhanced human hematopoiesis. Targeted at immuno-oncology and hematology researchers.

8Diet-Induced Obese (DIO) B6 Mouse
CategoryDiet-Induced Disease Models
Description

High-fat diet induced obesity mouse model on C57BL/6NTac background for studying obesity, insulin resistance, and metabolic disorders. Priced at $105 per male mouse (7-9 weeks) and $39 per control male. Targeted at metabolic disease and obesity researchers.

9Diet Induced MASH B6 Mouse
CategoryDiet-Induced Disease Models
Description

Off-the-shelf diet-induced Metabolic Dysfunction-Associated Steatohepatitis (MASH) mouse model for preclinical drug discovery research in liver disease.

10C57BL/6 (B6) Mouse
CategoryStandard Inbred Mouse Strains
Description

Standard inbred mouse strain widely used in preclinical research, genetic engineering, and as a platform for genetically modified models. Targeted at general biomedical researchers.

11Sprague Dawley Rat
CategoryStandard Outbred Rat Strains
Description

Outbred rat model widely used in toxicology, neuroscience, and cardiovascular research, valued for rapid growth and robust reproductive performance. Priced at $36.25 per female rat (3-4 weeks). Targeted at toxicology and pharmacology researchers.

12Swiss Webster Mouse
CategoryStandard Outbred Mouse Strains
Description

Outbred mouse strain used for decades as an all-purpose stock for research, drug safety testing, and as recipient mothers in transgenic labs. Priced at $17.00 per female mouse (3-4 weeks).

13Standard Immunodeficient Models
CategoryImmunodeficient Models
Description

Immunodeficient mouse and rat models for xenograft studies and human tissue engraftment research. Targeted at oncology and transplantation researchers.

14Germ-Free Mice
CategorySpecialty Mouse Models
Description

Axenic mouse models free of all microorganisms for gnotobiotic and microbiome research studies. Targeted at microbiome and infectious disease researchers.

15Neurobiology Models Portfolio
CategoryDisease-Specific Research Models
Description

Mouse models for neuroscience research including Alzheimer's disease models, Parkinson's disease models, neuropsychiatric disorder models, and humanized apoE models for sporadic Alzheimer's. Targeted at CNS researchers.

16Blood-Brain Barrier Transport Platform
CategoryDisease-Specific Research Models
Description

Humanized receptor-mediated transport (RMT) models for CNS drug delivery evaluation using humanized TfR1 and CD98hc for receptor-mediated transport and brain exposure studies. Targeted at CNS drug developers.

17Oncology & Immuno-Oncology Models Portfolio
CategoryDisease-Specific Research Models
Description

Comprehensive portfolio of mouse and rat models for cancer research including syngeneic tumor models, spontaneous tumor models, and transgenic HLA models. Targeted at oncology drug discovery researchers.

18IBD Portfolio
CategoryDisease-Specific Research Models
Description

Mouse models for inflammatory bowel disease research including colitis models for drug development studies. Targeted at gastroenterology and IBD researchers.

19ADMET Portfolio
CategoryADMET Testing Services
Description

Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) testing services including xenoreceptor, transporter, and cytochrome P450 panel portfolios. Targeted at drug metabolism and safety pharmacology researchers.

20ExpressMODEL® Custom Model Generation Services
CategoryCustom Model Generation Services
Description

Rapid custom genetically engineered rodent model generation service using CRISPR/Cas9 gene editing, ES cell targeting, and random insertion transgenesis to produce knockout, knock-in, transgenic, and knockdown mice and rats. Targeted at researchers needing specific genetic modifications on accelerated timelines.

21Colony Management Solutions
CategoryColony Management Services
Description

Expert planning and agile project management services for animal husbandry, breeding, health monitoring, animal conditioning, accelerated backcrossing, and study animal supply. Targeted at researchers requiring continuous supply of specific model strains.

22Flow Cytometry Services
CategoryLaboratory Analytical Services
Description

Flow cytometry analysis services for immune profiling and cellular characterization in preclinical studies. Targeted at immunology and cell biology researchers.

23Cryopreservation and Cryorecovery Services
CategoryEmbryology Services
Description

Embryology services for germplasm preservation including cryopreservation, cryorecovery, rederivation, and rapid expansion. Targeted at researchers requiring long-term preservation or recovery of specific model strains.

24Genotyping and Genetic Analysis Services
CategoryGenetic Analysis Services
Description

Genetic analysis and genotyping services for verifying model genetics and genetic monitoring programs. Targeted at researchers requiring confirmation of genetic background of breeding colonies.

25Microbiome Solutions
CategoryMicrobiome Research Services
Description

Services for microbiome research including germ-free mouse models and microbiome analysis for preclinical studies. Targeted at microbiome and infectious disease researchers.

26Protein Analysis Solutions
CategoryLaboratory Analytical Services
Description

Protein analysis services for biomarker identification and validation in preclinical research. Targeted at researchers conducting molecular characterization studies.

27Biospecimen Collection
CategoryBiospecimen Products
Description

Murine biospecimen collection services providing blood, plasma, serum, liver, adipose tissue and other tissue types with various preservation methods. Targeted at researchers requiring consistent biological samples.

28Phenotypic Data Packages
CategoryReference Data Products
Description

Phenotypic characterization data packages providing detailed physiological and biochemical parameters for specific models. Targeted at researchers requiring reference data on specific strains.

29eTACONIC® Platform
CategoryCustomer Operations Platform
Description

Online customer portal for tracking colony management and model generation projects with real-time access to colony inventory. Targeted at customers with active breeding and custom model projects.

30TransCure bioServices
CategoryPreclinical Research Services
Description

Preclinical in vivo research services in Oncology, Inflammation, and Infectious Diseases, providing translational pharmacology, preclinical imaging, and immune profiling capabilities for bi-specific antibodies, CAR-T therapies, and antibody-drug conjugates. Targeted at advanced therapy developers requiring specialized preclinical study services.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-20
Description

Acquisition of TransCure bioServices on January 20, 2026 significantly expanded Taconic's capabilities in immune system humanization (HIS) models and translational pharmacology platforms. The acquisition enhanced Taconic's portfolio of patient-derived xenograft (PDX) models and added expertise in specialized humanized mouse models for oncology and immunology research applications. TransCure's European presence also strengthened Taconic's market position in the region.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Taconic Biosciences

Preclinical Research Modelstaconic.com

Taconic Biosciences is a privately held US-based supplier of genetically engineered rodent models and humanized mouse platforms for pharmaceutical, biotech, and academic preclinical research, offering custom model generation, colony management, and translational research services.

What Taconic Biosciences does

Taconic Biosciences is a US-headquartered, privately held supplier of genetically engineered rodent models and preclinical research services, founded in 1949 and operating facilities in Germantown and Hudson, New York, with additional offices in Copenhagen, Denmark, and a France-based subsidiary (TransCure bioServices) acquired in January 2026. The company's portfolio centers on proprietary mouse and rat models — including the CIEA NOG immunodeficient platform, humanized immune system (HIS) variants such as NOG-EXL, NOG-hIL-2/6/15, FcResolv, and the NeoThy engraftment platform — as well as standard strains, diet-induced disease models (DIO B6, MASH B6), and germ-free mice. Custom model generation is delivered through the ExpressMODEL platform using CRISPR/Cas9, ES cell targeting, and random insertion transgenesis, supported by the eTACONIC project management portal.

Taconic generates revenue through per-unit model sales (e.g., $17 for Swiss Webster, $36 for Sprague Dawley, $105 for DIO B6), project-based custom model development, and recurring colony management, breeding, and cryopreservation services. Additional service revenue comes from flow cytometry, genotyping, microbiome, biospecimen collection, and — following the TransCure acquisition — translational pharmacology and preclinical imaging. The go-to-market is direct enterprise sales via scientific account representatives serving three primary segments: pharmaceutical and biopharma companies, academic and university research institutions, and biotech companies. Taconic is recognized as one of three major global preclinical rodent model suppliers alongside Charles River and Jackson Laboratory, and it maintains multi-channel marketing through scientific conferences, the eTACONIC platform, and an academic grant program that includes the Smart Select free-trial offering.

Taconic Biosciences firmographics

Firmographics
Name
Taconic Biosciences
Legal name
Taconic Biosciences, Inc.
Website
https://taconic.com
Company type
Private
Founded year
1952
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Taconic Biosciences is a privately held US-based supplier of genetically engineered rodent models and humanized mouse platforms for pharmaceutical, biotech, and academic preclinical research, offering custom model generation, colony management, and translational research services.
Ownership category
akta.pro rank

Taconic Biosciences industry classification

Industry
Product category
Preclinical Research Models
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAAIAC
Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Preclinical rodent models
  • Humanized mouse models
  • Genetically engineered mice
  • Colony management services
  • Custom model generation

Where Taconic Biosciences is headquartered

Location

Headquarters

HQ city
Albany
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Taconic Biosciences business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Research Model Sales: Sale of standardized and specialty mouse and rat models including immunodeficient, humanized, and genetically engineered strains. Revenue generated through per-unit pricing of individual animals with varying prices based on strain, age, and genetic background.
  2. Custom Model Development Services: ExpressMODEL® program providing custom genetically engineered rodent model generation for researchers requiring specific genetic modifications. Projects scoped and priced based on model complexity and development timeline requirements.
  3. Colony Management and Breeding Services: Ongoing colony management, breeding, and production services for researchers requiring continuous supply of specific model strains. Services include colony expansion, cryopreservation, and rederivation.
  4. Scientific Consultation Services: Technical and scientific consultation on model selection, experimental design, and study implementation for preclinical research programs. Often bundled with product sales for enterprise customers.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goSwiss Webster Mouse - Standard pricing for outbred research mice
Unit PricingPay-as-you-goDIO B6 Mice - Diet-induced obesity model on C57BL/6 background
Unit PricingPay-as-you-goSprague Dawley Rat - Standard outbred rat model

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Taconic Biosciences product offering

Product offering

Core offering

Taconic Biosciences develops, breeds, and sells genetically engineered mouse and rat models along with supporting laboratory and colony management services for biomedical and preclinical drug discovery research. The portfolio includes immunodeficient and humanized mouse models (notably the NOG family), standard inbred and outbred strains, diet-induced disease models, and custom-generated models via the ExpressMODEL® platform, sold primarily to pharmaceutical companies, biotechnology firms, and academic research institutions.

Product overview

Taconic Biosciences is a global leader in genetically engineered rodent models and preclinical research services. The company's portfolio centers on mouse and rat models including genetically engineered models (knockout, knock-in, transgenic), immunodeficient models (NOG mice, humanized immune system mice), standard strains, and diet-induced disease models. Key product lines include the NOG mouse portfolio for immuno-oncology research, humanized mouse platforms (NeoThy, Humanized Liver), and metabolic disease models (DIO B6, Diet Induced MASH). Services encompass custom model generation (via ExpressMODEL CRISPR platform), colony management, flow cytometry, cryopreservation, microbiome solutions, and biospecimen collection. The company operates the eTACONIC customer portal for project tracking. Following the January 2026 acquisition of TransCure bioServices, the portfolio expanded to include translational pharmacology and preclinical imaging services.

Differentiator

Problem solved

Functional benefit

Brands

  • eTACONIC® Platform: Customer portal for custom breeding services providing real-time access to colony inventory.
  • TransCure bioServices

Products and services

  • Genetically Engineered Models (GEMs) Genetically engineered mouse and rat models including knockout, knock-in, transgenic, knockdown, and cryopreserved variants for preclinical research and drug discovery. Targeted at pharmaceutical, biotechnology, and academic research customers.
  • CIEA NOG Mouse Super immunodeficient NOG mouse model for oncology and immuno-oncology research, enabling human tissue engraftment for translational studies. Targeted at preclinical researchers studying human cancer and immune system function.
  • Humanized Immune System (HIS) Mice Human immune system engrafted mouse models enabling predictive evaluation of immunotherapies and immune-mediated responses. Targeted at immuno-oncology and immunology researchers in pharma and academia.
  • NeoThy Human Immune Engraftment Platform Human immune engraftment platform enabling physiologic human immune function in mice through thymic tissue and HSC engraftment, supporting HLA-restricted T cell development for immunology and immuno-oncology research.
  • Humanized Liver Mouse Platform Human hepatocyte-engrafted TK-NOG mice platform for liver-focused drug development and in vivo pharmacology services. Targeted at hepatology, infectious disease, and drug metabolism researchers.
  • FcResolv NOG Models Fc-engineered NOG mouse models designed for oncology research evaluating Fc-mediated antibody effector functions. Targeted at antibody therapeutic developers.
  • huNOG-EXL Model Portfolio Next-generation humanized NOG-EXL mouse models expressing human cytokines (hGM-CSF/hIL-3) for enhanced human hematopoiesis. Targeted at immuno-oncology and hematology researchers.
  • Diet-Induced Obese (DIO) B6 Mouse High-fat diet induced obesity mouse model on C57BL/6NTac background for studying obesity, insulin resistance, and metabolic disorders. Priced at $105 per male mouse (7-9 weeks) and $39 per control male. Targeted at metabolic disease and obesity researchers.
  • Diet Induced MASH B6 Mouse Off-the-shelf diet-induced Metabolic Dysfunction-Associated Steatohepatitis (MASH) mouse model for preclinical drug discovery research in liver disease.
  • C57BL/6 (B6) Mouse Standard inbred mouse strain widely used in preclinical research, genetic engineering, and as a platform for genetically modified models. Targeted at general biomedical researchers.
  • Sprague Dawley Rat Outbred rat model widely used in toxicology, neuroscience, and cardiovascular research, valued for rapid growth and robust reproductive performance. Priced at $36.25 per female rat (3-4 weeks). Targeted at toxicology and pharmacology researchers.
  • Swiss Webster Mouse Outbred mouse strain used for decades as an all-purpose stock for research, drug safety testing, and as recipient mothers in transgenic labs. Priced at $17.00 per female mouse (3-4 weeks).
  • Standard Immunodeficient Models Immunodeficient mouse and rat models for xenograft studies and human tissue engraftment research. Targeted at oncology and transplantation researchers.
  • Germ-Free Mice Axenic mouse models free of all microorganisms for gnotobiotic and microbiome research studies. Targeted at microbiome and infectious disease researchers.
  • Neurobiology Models Portfolio Mouse models for neuroscience research including Alzheimer's disease models, Parkinson's disease models, neuropsychiatric disorder models, and humanized apoE models for sporadic Alzheimer's. Targeted at CNS researchers.
  • Blood-Brain Barrier Transport Platform Humanized receptor-mediated transport (RMT) models for CNS drug delivery evaluation using humanized TfR1 and CD98hc for receptor-mediated transport and brain exposure studies. Targeted at CNS drug developers.
  • Oncology & Immuno-Oncology Models Portfolio Comprehensive portfolio of mouse and rat models for cancer research including syngeneic tumor models, spontaneous tumor models, and transgenic HLA models. Targeted at oncology drug discovery researchers.
  • IBD Portfolio Mouse models for inflammatory bowel disease research including colitis models for drug development studies. Targeted at gastroenterology and IBD researchers.
  • ADMET Portfolio Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) testing services including xenoreceptor, transporter, and cytochrome P450 panel portfolios. Targeted at drug metabolism and safety pharmacology researchers.
  • ExpressMODEL® Custom Model Generation Services Rapid custom genetically engineered rodent model generation service using CRISPR/Cas9 gene editing, ES cell targeting, and random insertion transgenesis to produce knockout, knock-in, transgenic, and knockdown mice and rats. Targeted at researchers needing specific genetic modifications on accelerated timelines.
  • Colony Management Solutions Expert planning and agile project management services for animal husbandry, breeding, health monitoring, animal conditioning, accelerated backcrossing, and study animal supply. Targeted at researchers requiring continuous supply of specific model strains.
  • Flow Cytometry Services Flow cytometry analysis services for immune profiling and cellular characterization in preclinical studies. Targeted at immunology and cell biology researchers.
  • Cryopreservation and Cryorecovery Services Embryology services for germplasm preservation including cryopreservation, cryorecovery, rederivation, and rapid expansion. Targeted at researchers requiring long-term preservation or recovery of specific model strains.
  • Genotyping and Genetic Analysis Services Genetic analysis and genotyping services for verifying model genetics and genetic monitoring programs. Targeted at researchers requiring confirmation of genetic background of breeding colonies.
  • Microbiome Solutions Services for microbiome research including germ-free mouse models and microbiome analysis for preclinical studies. Targeted at microbiome and infectious disease researchers.
  • Protein Analysis Solutions Protein analysis services for biomarker identification and validation in preclinical research. Targeted at researchers conducting molecular characterization studies.
  • Biospecimen Collection Murine biospecimen collection services providing blood, plasma, serum, liver, adipose tissue and other tissue types with various preservation methods. Targeted at researchers requiring consistent biological samples.
  • Phenotypic Data Packages Phenotypic characterization data packages providing detailed physiological and biochemical parameters for specific models. Targeted at researchers requiring reference data on specific strains.
  • eTACONIC® Platform Online customer portal for tracking colony management and model generation projects with real-time access to colony inventory. Targeted at customers with active breeding and custom model projects.
  • TransCure bioServices Preclinical in vivo research services in Oncology, Inflammation, and Infectious Diseases, providing translational pharmacology, preclinical imaging, and immune profiling capabilities for bi-specific antibodies, CAR-T therapies, and antibody-drug conjugates. Targeted at advanced therapy developers requiring specialized preclinical study services.

Companies that use Taconic Biosciences

Customer profile

Segments3 records

Ideal customer profiles3 records

Taconic Biosciences technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Taconic Biosciences partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • TransCure bioServicescoreStrategic or Co-development Partner · 20 January 2026Acquisition of TransCure bioServices on January 20, 2026 significantly expanded Taconic's capabilities in immune system humanization (HIS) models and translational pharmacology platforms. The acquisition enhanced Taconic's portfolio of patient-derived xenograft (PDX) models and added expertise in specialized humanized mouse models for oncology and immunology research applications. TransCure's European presence also strengthened Taconic's market position in the region.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Taconic Biosciences competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key highlights7 records

Customer concentration

Taconic Biosciences social profiles

Digital presence

Taconic Biosciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Taconic Biosciences leadership team

Management profile

Number of profiles

Profiles7 records

Taconic Biosciences subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Taconic Biosciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Taconic Biosciences M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Taconic Biosciences

What does Taconic Biosciences do?

Taconic Biosciences develops, breeds, and sells genetically engineered mouse and rat models along with supporting laboratory and colony management services for biomedical and preclinical drug discovery research. The portfolio includes immunodeficient and humanized mouse models (notably the NOG family), standard inbred and outbred strains, diet-induced disease models, and custom-generated models via the ExpressMODEL® platform, sold primarily to pharmaceutical companies, biotechnology firms, and academic research institutions.

Is Taconic Biosciences a public or private company?

Taconic Biosciences is a private company. It is classified as unknown and is currently operating.

When was Taconic Biosciences founded?

Taconic Biosciences was founded in 1952. It employs 501 to 1,000 people.

Where is Taconic Biosciences based?

Taconic Biosciences is headquartered in Albany, United States, in the North America region.

How does Taconic Biosciences make money?

Four revenue lines are on record. Research Model Sales are the primary driver. The others are custom Model Development Services, colony Management and Breeding Services and scientific Consultation Services.

Does Taconic Biosciences have an API?

No public API is recorded for Taconic Biosciences.

What industry is Taconic Biosciences in?

Taconic Biosciences's product category is Preclinical Research Models. Its primary akta.pro industry code is HLAAAIAC, Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogTaconic Biosciences and genOway Partner to Expand U.S. Access to Advanced Humanized Mouse ModelsTaconic Biosciences and genOway announced a strategic distribution agreement to expand U.S. access to genOway's target-specific humanized mouse models. The partnership adds new models to Taconic's portfolio, supporting research in T-cell engagers, CAR-T therapies, and other modalities. U.S. researchers can work directly with Taconic to discuss model availability and study-specific considerations.MarketScreenerGenOway teams up with Taconic Biosciences to accelerate in the United StatesGenOway partnered with Taconic Biosciences to accelerate its US presence, with Taconic purchasing GenOway's preclinical models and reselling them. The agreement aims to double GenOway's US business in a market estimated at over $1 billion annually. GenOway's stock fell 1.6% on the news.FinancialContent Business PageGENOWAY : Résultats du 1er semestre 2026 - Confirmation de l'objectif de 50 M EUR de revenus en 2028genOway reported H1 2026 revenue of €10.9M, up 10% year-over-year, and confirmed its 2028 revenue target of €50M. The company expects H2 growth driven by its catalog model and genOway Shanghai, with a new US distribution deal with Taconic Biosciences.FinancialContent Business PagegenOway annonce un accord de distribution stratégique exclusif avec Taconic Biosciences pour devenir le leader des modèles humanisés aux Etats-UnisgenOway signed an exclusive distribution agreement with Taconic Biosciences to expand its US preclinical model business. The deal aims to double genOway's US activity, with Taconic covering the entire US market. The agreement is expected to boost revenue and profitability.PR NewswireGlobal Oncology-Based In-Vivo CRO Market to Accelerate Substantially at a CAGR of ~8% by 2034 | DelveInsightThe oncology-based in-vivo CRO market is projected to grow from USD 1.5 billion in 2025 to USD 3.2 billion by 2034, a CAGR of ~8%. North America holds the largest share at ~45%, driven by a mature oncology pipeline and outsourcing trends. Growth is fueled by rising cancer burden, advanced animal models, and increased R&D investments.PR NewswireGlobal Oncology-Based In-Vivo CRO Market to Accelerate Substantially at a CAGR of ~8% by 2034 | DelveInsightThe oncology-based in-vivo CRO market is projected to grow from USD 1.5 billion in 2025 to USD 3.2 billion by 2034, a CAGR of ~8%. North America holds the largest share at 45%, driven by a mature oncology pipeline and outsourcing trends. Growth is fueled by rising cancer burden, advanced animal models, and increased R&D investments.GenengnewsNext Generation Biopharma InnovationMajor preclinical research model suppliers including The Jackson Laboratory, Charles River Laboratories, Taconic Biosciences, MIMETAS, and MilliporeSigma are launching advanced humanized mouse models and new approach methodologies (NAMs) to meet growing demand for translational models in immuno-oncology, neuroscience, and cardiometabolic drug development. Regulatory pressure from the FDA and European authorities to reduce reliance on animal testing is accelerating adoption of organoids, iPSCs, and organ-on-chip systems, with FDA issuing draft guidance in March 2026 to establish validation principles for NAMs in drug applications. Genmab's $8 billion acquisition of Merus, whose drug petosemtamab used HUB organoids to earn FDA Breakthrough Therapy Designation, illustrates how organoid technology is delivering real-world impact in biopharma.TaconicTaconic Biosciences Acquires TransCure bioServicesTaconic Biosciences announced the acquisition of TransCure bioServices SAS, a provider of preclinical research services using humanized immune system mouse models, on January 20, 2026. The transaction creates a unified global platform combining Taconic's genetically engineered rodent models and humanized mouse models with TransCure's translational pharmacology services, preclinical imaging, and immune profiling capabilities for drug discovery. The combined entity will support advanced therapeutic modalities including bi-specific antibodies, CAR-T therapies, and antibody-drug conjugates while expanding both companies' geographic footprint across American and European markets.PharmiWeb.comTaconic Biosciences Acquires TransCure bioServices, Building a Comprehensive Global Platform for Humanized Mouse Translational ResearchTaconic Biosciences acquired TransCure bioServices, a provider of preclinical research services involving humanized immune system mouse models, to establish a global research platform. The combined entity will support advanced drug discovery, particularly in immuno-oncology and other next-generation therapies, by integrating models, services, and expertise. This move aims to enhance the efficiency and reliability of translational research for biotech and pharmaceutical companies.Business Wire BlogTaconic Biosciences Acquires TransCure bioServices, Building a Comprehensive Global Platform for Humanized Mouse Translational ResearchTaconic Biosciences, a global leader in genetically engineered rodent models, announced its acquisition of TransCure bioServices SAS, a France-based provider of preclinical research services utilizing humanized immune system mouse models. The acquisition establishes a fully integrated translational research platform, combining Taconic's global production infrastructure and validated models with TransCure's expertise in disease-specific translational pharmacology, flow cytometry, and advanced in vivo study capabilities. The combined entity will support advanced therapeutic modalities including bi-specific antibodies, CAR-T therapies, and antibody-drug conjugates, expanding both companies' geographic footprint and service offerings for biotech and pharmaceutical researchers worldwide.